Jiangxi Fushine Pharmaceutical Co Ltd Class A 300497
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 10.21
- Day Range
- CNY 10.09–10.38
- 52-Week Range
- CNY 5.62–14.33
- Bid/Ask
- CNY 10.13 / CNY 10.14
- Market Cap
- CNY 5.58 Bil
- Volume/Avg
- 7.2 Mil / 12.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.52
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Jiangxi Fushine Pharmaceutical Co Ltd is engaged in research and development, manufactures and sells APIs and pharmaceutical intermediates. It offers penicillin, carbapenem, and other products.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Core
- Total Number of Employees
- 2,179
- Website
- http://www.fushine.cn
Comparables
Valuation
|
Metric
|
300497
|
603566
|
300966
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 48.24 | 90.81 |
Price/Book Value | 2.28 | 2.14 | 2.40 |
Price/Sales | 3.52 | 5.01 | 3.88 |
Price/Cash Flow | 53.20 | 24.18 | 21.79 |
Price/Earnings
300497
603566
300966
Financial Strength
|
Metric
|
300497
|
603566
|
300966
|
|---|---|---|---|
Quick Ratio | 1.09 | 2.52 | 0.73 |
Current Ratio | 1.48 | 3.00 | 1.61 |
Interest Coverage | −3.82 | — | 1.78 |
Quick Ratio
300497
603566
300966
Profitability
|
Metric
|
300497
|
603566
|
300966
|
|---|---|---|---|
Return on Assets (Normalized) | −3.63% | 3.63% | 1.07% |
Return on Equity (Normalized) | −6.86% | 4.33% | 2.56% |
Return on Invested Capital (Normalized) | −3.45% | 4.16% | 1.78% |
Return on Assets
300497
603566
300966
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Hygpxcbzy | Wckrz | $590.5 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Dzvpykx | Jgnpffx | $113.8 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Tcncxgnc | Gwxhbwq | $106.5 Bil | |
MRNA
| Moderna Inc | Rxvsnrsy | Kqx | $58.7 Bil | |
BNTX
| BioNTech SE ADR | Tfdcgldgf | Fysb | $23.8 Bil | |
ARGX
| argenx SE ADR | Nbxddmhf | Vwjc | $21.6 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Dvnjtltty | Wftfp | $19.0 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Ryfwcrt | Wrkknq | $14.1 Bil | |
INCY
| Incyte Corp | Dvgpktj | Gmxzww | $12.9 Bil | |
TECH
| Bio-Techne Corp | Mmpgzqvx | Kqpgnv | $12.2 Bil |